'Once a week insulin to be launched in India in 2025', says Novo Nordisk India MD Vikrant Shrotriya
What roles and opportunities does Novo Nordisk see for itself as India continues to struggle with growing burden of diabetes, obesity? Watch the company's India MD Vikrant Shrotriya , in conversation with ThePrint's Sumi Sukanya Dutta in #ThePrintInterview
---------------------------------------------------------------------------------------------
Exclusive content, special privileges & more - Subscribe to ThePrint for Special benefits: theprint.in/subscribe/
---------------------------------------------------------------------------------------------
Connect with ThePrint
» Subscribe to ThePrint: theprint.in/subscribe/
» Subscribe to our KZread Channel: bit.ly/3nCMpht
» Like us on Facebook: / theprintindia
» Tweet us on Twitter: / theprintindia
» Follow us on Instagram: / theprintindia
» Find us on LinkedIn : / theprint
» Subscribe to ThePrint on Telegram: t.me/ThePrintIndia
» Find us on Spotify: spoti.fi/2NMVlnB
» Find us on Apple Podcasts: apple.co/3pEOta8
Пікірлер: 11
In recent years, it appears like lifestyle related disorders have killed more people than the natural ageing and life cycle. The same needle prick does have different impact on different individual, it's not as easy for everyone. This wealth of information coming from Vikrant Shrotria of Novo Nordisk about comforting diabetic patients from daily needles to weekly is certainly a breakthrough. The innovation and range of product pipeline to improve lifestyle conditions is a welcome development 👏
Once a week Once a month Once a year Once in ten year Once in a lifetime.
The real question is how much price would it be available for, even though there are insulin pumps and continuous monitoring meters large quantity of t1ds cannot afford it.
Dr Shrotiya Great News.Heartiest congratulations for your relentless Hard work.
Thanks for covering this
But oral semeglutide is very costly. Decrease the rate at least 75% . Otherwise mass public cannot afford the cost.
is it true nd can v use for type 1 my child
What a boon it is to have oral semaglutide in India, it has been a true game changer for people living with type 2 diabetes to manage their blood sugar and weight. I personally know of people within my family that are on this drug and it has completely changed the way they feel both physically and psychologically, not to mention their diabetes is completely under control. Novo Nordisk at its best in terms of bringing such innovations and truly changing diabetes!
Semaglutide oral easily available in urban centres.
Vikrant 👍
Best innovations available to people.